Drug intelligence / Profile preview

Recombinant Varicella Vaccine (Grand Theravac Life Sciences)

Development stage: Unknown
Lead developer: Grand Theravac Life Science Nanjing
Modality: Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration: Injection

Overview

The Recombinant Varicella Vaccine is a prophylactic vaccine candidate developed by Grand Theravac Life Sciences for the prevention of varicella (chickenpox). Utilizing recombinant protein technology, the vaccine is designed to elicit a protective immune response against the Varicella-Zoster Virus (VZV). Unlike traditional live-attenuated varicella vaccines, this recombinant approach aims to provide a safe and effective alternative by using specific viral antigens. The vaccine has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA), positioning it for clinical evaluation.

Other names: Recombinant Varicella Vaccine

Beyond the preview

Go deeper on Recombinant Varicella Vaccine (Grand Theravac Life Sciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recombinant Varicella Vaccine (Grand Theravac Life Sciences).

Explore the full profile